CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue:
Total revenue	$ 900,195	$ 836,549
Cost of Revenue:
Cost of revenue	357,224	337,796
Gross profit	542,971	498,753
Expenses:
Sales and marketing	147,804	132,292
General and administrative	70,101	77,949
Research and development	44,667	40,168
Income from operations	280,399	248,344
Interest expense	(13,127)	(6,996)
Interest income	416	143
Income before provision for income taxes	267,688	241,491
Provision for income taxes	53,634	47,526
Net income attributable to IDEXX Laboratories, Inc. stockholders	$ 214,054	$ 193,965
Earnings per Share:
Basic (in USD per share)	$ 2.58	$ 2.30
Diluted (in USD per share)	$ 2.55	$ 2.27
Weighted Average Shares Outstanding:
Basic (in shares)	82,992	84,410
Diluted (in shares)	83,959	85,564
Product revenue
Revenue:
Total revenue	$ 505,942	$ 478,377
Cost of Revenue:
Cost of revenue	173,610	162,071
Service revenue
Revenue:
Total revenue	394,253	358,172
Cost of Revenue:
Cost of revenue	$ 183,614	$ 175,725